Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPB-06 in portal vein thrombosis
NCT02250391Phase 3Completed
- Sponsor
- Nihon Pharmaceutical
- Start
- Sep 2014
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
A Phase 3 trial of artemether + lumefantrine in portal vein thrombosis (PVT), sponsored by Nihon Pharmaceutical. Started Sep 2014; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT02250391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250391.